STEPHANIE TWOREK: Open Payments
NPI 1689329773 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 73 payments from 10 companies in 2025. Trend: 2023 $917 · 2024 $818 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 20 | $327 |
| Gilead Sciences, Inc. | 16 | $305 |
| ABBVIE INC. | 15 | $176 |
| Merck Sharp & Dohme LLC | 7 | $168 |
| La Jolla Pharmaceutical Company | 6 | $112 |
| Melinta Therapeutics, LLC | 3 | $59 |
| Reprise Biomedical, Inc. | 2 | $50 |
| Insmed, Inc. | 2 | $46 |
| Smith+Nephew, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $17 |
Products named: DOVATO, ZERBAXA, DALVANCE, CABENUVA, EMBLAVEO, XACDURO, PIFELTRO, RUKOBIA.
Industry payments across TN — which companies pay providers there.
